FiercePharma

Abbott Receives FDA Approval for CREON® (Pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficienc

ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) ...
PharmTech

In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model

International Journal of Pharmceutics: In Vitro: The dissolution characteristics of five capsules (Next Generation Enteric [NGE], Vcaps® Enteric [VCE], VCE DUOCAP® [VCE/VCE] system, Hard Gelatin ...
Monthly Prescribing Reference

Creon delayed-release capsules available for exocrine pancreatic insufficiency

CREON (Lipase, amylase, protease) e-c minimicrospheres in capsules by AbbVie Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a "zero-overfill" pancreatic ...
Monthly Prescribing Reference

Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis

CREON (Lipase, amylase, protease) e-c minimicrospheres in capsules by AbbVie Creon (pancrelipase, from Solvay Pharmaceuticals) delayed-release capsules, a pancreatic enzyme product (PEP), has received ...
Medscape

FDA Approves Creon Delayed Release Capsules for Pancreatic Insufficiency

May 7, 2009 — Pancrelipase (Creon, Solvay Pharmaceuticals, Inc) delayed-release capsules were approved by the US Food and Drug Administration (FDA) for treatment of exocrine pancreatic insufficiency ...
FiercePharma

Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectom

Uses CREON (pancrelipase) Delayed-Release Capsules is a prescription pancreatic enzyme medicine used to improve food digestion in people who cannot digest food properly because they have exocrine ...
Pharmabiz

Abbott gets US FDA nod for CREON infant-specific dosage for patients with EPI due to cystic fibrosis

Abbott announced that the US Food and Drug Administration (FDA) has approved an infant-specific dose of CREON (pancrelipase) delayed-release capsules to treat Exocrine Pancreatic Insufficiency (EPI) ...
News Medical

Creon Capsules

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. CREON contains the active ingredient Pancreatic extract. CREON is used ...
Finanznachrichten

AbbVie Announces Market Availability of New CREON (pancrelipase) 36,000 Lipase-unit Capsules for Patients with Exocrine Pancreatic Insufficiency

NORTH CHICAGO, Ill., May 30, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that a new, higher-dose capsule of CREON ® (pancrelipase) Delayed-Release Capsules is commercially available in ...
BBC

Shortage of key drug 'frightening' for patients

John Swale, from Rotherham, says he is frightened by the thought of being without Creon A nationwide shortage of a drug designed to help people digest food is causing fear and frustration among ...
Medscape

UK Pharmacies Struggle With Severe Creon Shortage

Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned. A sample survey by the association ...